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NuNec™ cervical disk arthroplasty improves quality of life in cervical radiculopathy and 
myelopathy: a two-year follow-up.  
 
Abstract  
BACKGROUND: Anterior cervical disk replacement is an alternative to fusion for the treatment 
of selected cases of radiculopathy and myelopathy. We report clinical and radiological outcomes 
after disk replacement with the NuNec™ artificial cervical disk with subgroup analysis. 
OBJECTIVE: To review clinical and radiological outcomes after anterior cervical disk 
replacement with the NuNec™ artificial cervical disk. 
METHODS: A consecutive case series of patients undergoing cervical disk replacement with the 
NuNec™ artificial disk. Clinical outcomes were assessed by questionnaires pre-operatively and 
up to two years post-operatively including neck and arm pain, Neck Disability Index, Euroqol 5-
dimensions, and Short Form-36; x-rays from the same period were analyzed for range of 
movement and presence of heterotopic ossification. 
RESULTS: Forty-four NuNec™ disks were implanted in 33 patients. Clinical improvements 
were seen in all outcomes; significant improvements on the Neck Disability Index, Euroqol 5-
dimensions and physical domain of the Short Form-36 were maintained at two years. There was 
a mean of 4 degrees range of movement at the replacement disk level at two years, a significant 
reduction from baseline; there was also progression in levels of heterotopic ossification. 
Complications included temporary dysphagia (10%) and progression of disease requiring 
foraminotomy (6%); no surgery for adjacent level disease was required. There was no significant 
difference in the outcomes of the radiculopathy and myelopathy groups. 
CONCLUSION: Clinical outcomes using the NuNec™ disk replacement are comparable with 
other disk replacements. Although range of movement is reduced, re-operation rate is very low.  
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ASD, Adjacent segment disease 
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Introduction 
Anterior cervical disk replacement (ACDR) has gained popularity as an alternative surgical 
option to anterior cervical diskectomy and fusion (ACDF) for degenerative disk disease 1-3. 
Studies of post-operative outcomes after ACDR have shown equitable or slightly improved 
clinical and radiological outcomes, when compared with ACDF at 2-5 years 4-9, together with 
superior cost-effectiveness 10,11. There are currently no studies of the efficacy of the NuNec disk 
replacement, and additionally there is currently little information about whether outcomes are 
different for patients presenting with myelopathy, as opposed to radiculopathy. Reports have 
suggested that patients with myelopathy are generally older, have a more advanced condition, 
but show similar outcomes to those with radiculopathy 12,13. 
Cervical disk replacements aim to maintain movement at the symptomatic level, theoretically 
reducing the risk of adjacent segment disease (ASD) although a causative relationship between 
ACDF and ASD has not been formally proven 2. Maintenance of movement has been 
demonstrated in over 80% of patients 1,14-16. In ACDR, the prosthesis generates biomechanical 
conditions closer to physiological parameters by maintaining motion at the affected level, 
whereas ACDF results in reduced movement of the affected vertebrae, particularly after fusion of 
more than one level 7. As a consequence, adjacent joint movement increases and adjacent disk 
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pressure is greater after fusion 7,17,18. 
Range of movement after ACDR is not always preserved in part due to the development of 
heterotopic ossification (HO) 19. The development of which has been attributed to a number of 
factors, including natural progression of degeneration 20, as well an iatrogenic causes 19,21,22, 
which may be aggravated by reduced movement 23. Disk replacements vary by material and 
design, which affect both motion preservation and wear and tear characteristics, and 
consequently the risk of HO development 24.  
The NuNec™ disk replacement (Pioneer® Surgical Technology, Marquette, MI, USA) has a 
semi-constrained ball and socket design with an integrated cam locking system (see Figure 1). It 
is largely radio-lucent on x-ray and MRI imaging 25. The NuNec™ device is made from the 
polymer, Polyether-ether-ketone (PEEK), which differs from frequently used artificial disks such 
as the Bryan Disk, Prestige, PCM and ProDisc-C, which use metal alloys and ultrahigh 
molecular weight polyethylene; it has a hydroxyapatite covering to encourage bony ingrowth. 
The NuNec™ prosthesis has high radiation, thermal and aging resistance, good mechanical and 
biological performance and generates smaller wear particles than some other disks, which may 
reduce the immune response that accelerates osteolysis 26.  
 
 
Figure 1: NuNecTM disk replacement A: 3D B: Sagittal plane 
 
The purpose of our study was to evaluate current data from a single site regarding the NuNec™ 
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cervical disk replacement; we present two-year follow-up clinical and radiographic data 
including subgroup analysis for patients presenting with myelopathy and radiculopathy. 
Methods 
We prospectively collected data from a consecutive series of patients who presented to a single 
spinal surgery unit in London, UK with cervical radiculopathy or myelopathy and underwent 
ACDR, having given written consent, from 2009 to 2016. Patients were considered for cervical 
disk replacement if symptoms resulted from spondylotic disease; movement at the affected level 
was evident on dynamic flexion/extension x-rays; and they had undergone at least six weeks of 
unsuccessful conservative management, which might include anti-inflammatory and analgesic 
medications, physical therapy and nerve root or epidural injections. Contra-indications to ACDR 
included rheumatoid arthritis, osteoporosis, trauma, spinal tumour, infection, severe degenerative 
facet disease, ossification of the longitudinal ligament, and spine instability. Patients were 
undergoing routine clinical care and follow-up, as a result, ethical approval was not required. 
Surgery was performed through a right-side transverse skin-crease neck incision, using a 
standard anterior cervical retractor system. Subperiostial dissection of the longus colli muscles 
was performed to expose the disk space. An interbody disk distractor or vertebral body pin 
distracter was used. Diskectomy was performed under the microscope with a high-speed drill, 
curettes, and Kerrison rongeurs, and the posterior longitudinal ligament was divided in all cases. 
After the endplates were decorticated to allow a close fit with the surface of the replacement an 
appropriately sized disk replacement was inserted.  
Prospective clinical outcome measures were collected pre-operatively and by postal 
questionnaire at 3, 6, 12 and 24 months, including Visual Analogue pain score for neck pain 
(VAS neck) and for arm pain (VAS arm), Neck disability index (NDI), Euroqol (EQ-5D) health 
status and Short form 36 (SF-36). Dynamic x-rays were taken as was deemed relevant for 
clinical follow-up, and were matched to the time points above. X-rays were assessed for affected 
level range of movement by measuring the angle change between the superior and inferior 
endplates using lines drawn between bony points anteriorly and posteriorly that were 
reproducible on each pair of flexion/ extension x-rays pre-operatively, and tips of the radiolucent 
anterior aspect and the radiolucent marks at the rear of the implant post-operatively; a lordotic 
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angle was taken as a positive value and kyphotic angle as negative (Figure 2). Each level was 
measured five times by the same researcher and the average taken; reliability was assessed by 
using the intra-class correlation coefficient and comparing residuals to mean movement change. 
<2° of measured movement was considered equal to fusion 1,15,16. 
 
     
Figure 2: Angular measurements to assess movement at the operated level between flexion and 
extension. A: pre-operatively, B: post-operatively 
 
Lateral x-rays were also used to assess the presence of HO using the modified McAfee score, 
which ranges from 0 (no HO) to 4 (fusion) 27, grades 3 and 4 were taken as being clinically 
significant 14. 
Results were explored using descriptive statistics, and hypothesis testing for differences between 
baseline and 2 years for clinical and radiological data, using the paired t-test for continuous data, 
Mann-Whitney U test for categorical data and Spearman rank correlation coefficient to 
investigate relationships; significance was set at P=.05. All analysis was carried out using Stata 
13 (StataCorp, College Station, Texas, USA). 
Results 
From a total of 43 patients, 33 patients had been followed up for two years. 13 were male (39%) 
and mean age was 48.3 (SD 8.7). 14 presented with radiculopathy, 12 with myelopathy and 4 
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with a mixed picture. Of patients presenting with an element of myelopathy, 8 presented with 
soft disk hernia, 3 with osteophytes, and 4 with a mixed picture. Clinical details were unavailable 
in 3 patients (Table 1). 
 
Gender: male n (%) 13 (39.4%) 
Age: mean (SD) 48.3 (8.7) 
Underlying problem: n (%) 
Radiculopathy 
Myelopathy 
Mixed 
 
14 (46.7%) 
12 (40.0%) 
4 (13.3%) 
Number of disks replaced: n 
(%) 
1 
2 
3 
 
23 (70%) 
9 (27%) 
1 (3%) 
Level of disk replaced: n (%) 
C3/4 
C4/5 
C5/6 
C6/7 
 
5 (11%) 
8 (18%) 
20 (45%) 
11 (25%) 
 
Table 1: Subject demographics 
 
A total of 44 NuNec™ disk replacements were implanted. The majority of patients had one-level 
operations (23, 70%), 9 had two-level operations (27%) and 1 patient had a three-level disk 
replacement operation (3%) according to clinical need and radiological findings. Five (11%) of 
the replacements were at C3/4, 8 (18%) at C4/5, 20 (45%) at C5/6 and 11 (25%) at C6/7. 
Clinical outcomes 
All clinical outcomes had improved at the two-year follow-up, although significant variability 
was seen. Baseline and two year follow-up data was available for 82%, 82%, 82%, 76% and 85% 
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of patients who had reached two years post-operatively, for VAS neck, VAS arm, NDI, EQ5D 
and SF36 respectively. There were no significant differences between changes seen for the 
radiculopathy or myelopathy groups for any of the clinical variables. 
The pattern of pain reduction is shown in Figures 3a and 3b. Broadly, the largest reduction is 
seen at six months, with some return of pain over a longer time scale. At two-year follow-up, 
neck and arm pain were no longer significantly improved (P=.28; P=.24). Average reduction in 
neck pain at two years was -0.58 (95%CI -1.65, 0.49) from a baseline of 3.69, whilst reduction in 
arm pain was -0.66 (95%CI -1.78. 0.46) from 3.17. When radiculopathy and myelopathy 
subgroups were analyzed separately, neither demonstrated significant improvements for neck 
pain (mean change (95% CI) -0.18 (-1.58, 1.94) P=.83; -0.92 (-2.62, 0.77) P=.26) or arm pain (-
0.48 (-1.95, 0.99) P=.49; -0.74 (-2.89, 1.42) P=.46). 
 
     
     
Figure 3: Change in clinical outcomes over time, mean and 95% CIs. A: VAS neck, B: VAS 
arm, C NDI, D: EQ5D index, E: SF36 PCS, F: SF36 MCS. 
 
The NDI demonstrated significant improvement at two year follow-up (P<.01), with 
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improvements seen by six months and maintained at two years (Figure 3c); the mean reduction 
in score was -9.0 points (95%CI -14.2, -3.9) from a pre-operative score of 33.81. Separate 
subgroup analysis demonstrated significant improvements in both the radiculopathy and 
myelopathy subgroups (mean change (95% CI) -9.86 (-18.56, 1.15) P=.03; -10.36 (18.55, 2.17) 
P=.02 respectively). 
EQ5D also demonstrated significant improved health status at follow-up (P<0.01), some 
improvement was seen initially, peaking at six months (Figure 3d). The mean improvement was 
0.12 (95% CI 0.04, 0.20) from a pre-operative mean of 0.56. In the subgroup analysis, significant 
improvement was seen in the radiculopathy group (mean change (95% CI) 0.18 (0.06, 0.31) 
P<.01), but not in the myelopathy group (0.08 (-0.02, -0.19) P=.11). 
The physical sub-score (PCS) of the SF36 demonstrated a similar pattern to the other outcome 
measures, improving to six months and then plateauing, whilst the mental sub-score (MCS) 
demonstrated more variability after six months (Figure 3e and f). At two-year follow-up, the 
improvement in PCS was significant (P=.02), which was not demonstrated in the MCS (P=.17). 
The average improvement in the PCS was 4.01 (95% CI 0.64, 7.38) from a baseline score of 
35.06, the MCS improvement was 3.69 (95% CI -1.67, 9.06) from 46.62. In the subgroup 
analysis the PCS remained significant improved in the radiculopathy group but not the 
myelopathy group (mean change (95% CI) 6.05 (1.15, 10.94) P=.02; 3.68 (-2.70, 10.07) P=.23), 
whilst both groups were not significantly improved on the MCS scale (7.11 (-0.79, 15.02) P=.07; 
5.18 (-3.06, 13.42) P=.19). 
Radiological outcomes  
Radiological data was available for 17 (52%) patients at one year and 12 (36%) at two years, and 
for 23 (52%) operated levels at one year and 15 (34%) at two years post-operatively; flexion/ 
extension xrays were not considered clinically necessary in a number of cases, accounting for the 
low follow-up rate. Repeated measures of each x-ray resulted in residuals of less than 1° across 
all measurements (0.99, 95% CI 0.92, 1.06), and individual ICC was greater than 0.76 at all time 
points, demonstrating good intra-rater reliability. 
Average movement between flexion and extension at the index level was 6.6° preoperatively, 
and 4.0° after two years. Paired baseline and follow-up data available from 13 levels 
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demonstrated that average angle change was -3.38° (95% CI -6.00, -0.75), a statistically 
significant reduction (P=.02). 72.7% of operated levels demonstrated >2° of movement at 
follow-up, the progression can be seen in Figure 4. Subgroup analysis did not demonstrate a 
significant reduction in range of movement in the radiculopathy group, but was significant in the 
myelopathy group (mean (95% CI) -3.72° (-10.14, 2.70) P=.18; -3.07 (-6.03, -0.11) P= .04 
respectively).There was no significant difference in the group changes, P=.76. 
 
Figure 4: Range of movement at the index level over time, mean with 95% confidence intervals. 
 
Clinically significant HO was seen at five levels (10.8%) pre-operatively, all with level 3 HO. 
There was significantly more HO at follow-up (P<.01); 53.3% of levels demonstrated clinically 
significant HO at two years post-operatively, split evenly between levels 3 and 4 (Figure 5). 
There was a significant relationship linking increased HO with reduced movement at the index 
level (r=-0.25, P<.01) (Figure 6). There was no significant trend seen in either the radiculopathy 
or myelopathy subgroups (r=-0.23, P=.07; r=-0.15. P=.24 respectively). 
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Figure 5: Level of HO at the index level over time. 
 
Figure 6: Relationship between the change in level of HO and change in range of movement at 
the index level. r=-0.25, P<.01 
 
Complications 
A cohort of 30 patients was followed up at the surgical hospital. Three patients (10.0%) had 
temporary dysphagia lasting less than three months and none required further treatment. Two 
patients required foraminotomy at the index level for recurrence of symptoms, beyond 18 months 
after the initial operation. No operations were carried out for adjacent segment disease. 
Discussion 
This report details the clinical and radiographical outcomes of a cohort of patients who 
underwent ACDR at a single spinal center, and is the first published clinical data for the 
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NuNec™ disk replacement including subgroup analysis of radiculopathy and myelopathy 
patients. 
Clinical benefits 
Equitable or improved clinical outcomes have been demonstrated when comparing ACDR to 
fusion, using various other disk prostheses 4-8,28. The two-year post-operative scores from our 
patient group demonstrate clinical improvements in line with recent large-scale studies 4-8,28-30; 
however the percentage improvement is not as large. The results here are likely to be impacted 
by a lower operating threshold: pre-operative VAS neck scores of 3.7 in this group demonstrate 
less impairment than seen in the study by Burkus et al 4, in which patients demonstrated an 
average VAS of 6.8. This pattern is repeated across the other clinical outcome measures; similar 
reduced impairment is seen with VAS arm at 3.2 pre-operatively compared to 5.91 in the study 
by Burkus et al., NDI 33.8 and 55.7, EQ5D 0.56 and 0.42, SF36 PCS 35.1 and 31.9, lastly SF36 
MCS 46.6 and 42.3, the values for EQ5D and SF36 MCS are taken from studies by Heller et al. 
and Schluessmann et al. 6,31. 
 
Following neck surgery for radiculopathy or myelopathy, short term improvement in symptoms 
is frequently seen immediately after surgery for patients with radiculopathy, and by six months 
for patients with myelopathy, whilst ongoing degenerative disease processes or long term 
surgical sequelae may impede further improvement 20. Our results suggest that both groups of 
patients may clinically benefit from ACDR, and that there is a trend to these benefits being 
maintained for longer in patients with radiculopathy. This is in line with a large retrospective 
review of 5256 patients by Lukasiewicz et al 13, who suggests that myelopathy is a more 
advanced condition, and that these patients may generally be older, less healthy and have 
significantly greater risk of morbidity, although this was not found in smaller series 12. 
Movement maintenance and radiological changes 
The ability to maintain movement at the operated level is key to the theoretical benefit of ACDR 
when compared to ACDF 32 however, a recent systematic review did not identify a relationship 
between post-operative range of movement, or HO development and clinical outcomes 33; 
nevertheless, theoretically the reduction in symptoms or need for future re-operations for 
adjacent segment disease would represent a significant benefit. 
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In our patient group, maintained or improved movement is seen at the operated level up to the six 
month follow-up; after this there is a gradual but significant reduction in movement to a mean of 
4.0° at two years (P= .02), demonstrated in Figure 4; at this stage 72.7% of operated levels 
showed greater than 2° of movement. Other studies have demonstrated movement in 82.9- 88% 
of operated levels at two years 1,14,15. This may be a result of clinical bias from loss to follow-up, 
as the small cohort of patients with 24 month dynamic x-rays are more likely to be those with 
greater impairment. Interestingly, range of movement at baseline, 6.6°, is lower when compared 
to other recent studies, which reported range of movement of 7.5-12.8°7,14,34. Whilst this could be 
a difference in x-ray methodology and ability to ellicit full range of movement for imaging, this 
difference may suggest that our cohort had greater mechanical impairment preoperatively which 
could influence the results, Ahn 35 suggested that fear of extremes of movement may limit neck 
range of movement on dynamic x-ray.  
The development of clinically significant HO is reported in 0- 33% of cases at 2 years after 
surgery 1,21,36,37 and has been implicated as a factor in the reduction of range of movement 24, this 
is supported by our results (Figure 6). The objectivity of HO measurement has come under 
scrutiny, Choi 38 suggested that ‘the more you look, the more you see’, and variability in 
measurement has also been linked to bias from conflicts of interest 2; many studies have 
formalized this by using the McAfee scale 14. Yi et al.24 report that there is a trend toward 
progression in HO, as measured by the McAfee scale, from a mean of 0.9 at baseline to 1.5 at 
three years. Our patient group demonstrated greater HO at both baseline (mean 1.2) and follow-
up (mean 2.6), (Figure 5), with 10.8% of operated levels showing grade 3 or 4 HO at baseline, 
and 53.3% after two years. This progression is statistically significant and whilst this may be a 
result of the mechanical features of the NuNec™ device or an iatrogenic response to bone 
drilling, it may also be due to clinical bias as noted above, ongoing disease processes 20, or 
greater baseline impairment: Yi et al. 24 report that greater degrees of HO at follow-up are seen in 
patients with greater HO at baseline. Of note, in our myopathy cohort, 47% had an element of 
osteophyte formation that contributed to the surgical indication. Future research may identify if 
maintaining movement in this patient group, even if short term, is beneficial. 
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The development of HO and reduction of range of movement is only of interest if it is clinically 
significant. The clinical outcome measures in our patient group largely plateau after six months, 
whereas this is the time point of reduction in range of movement and development of HO, 
suggesting the two are not closely related. The re-operation rate at two years in this cohort, 6.7%, 
is marginally higher than seen in the literature for ACDR at two years (2-6%) 1,4-8,28-30, and may 
be a consequence of the small sample size, as this only related to two patients. Notably this is no 
higher than the range of re-operation rates from recent large studies for ACDF (4-9%) 1,4-8,28-30 
and whilst there may be concerns about late-failure of devices, the small cohort of 21 patients in 
the study by Quan et al. 23, did not require any re-operations at eight years. Of note in our cohort, 
there was no need for surgery of the adjacent segment, and no significant, long-term 
complications, which have been seen in 3-8% and 9-39% of patients in recent large studies of 
ACDR 1,4-8,28-30. 
Limitations 
Small sample size and low follow-up rates, particularly for dynamic x-rays, may bias our results, 
however, as there is minimal data regarding the outcomes of NuNecTM disk replacement, we 
considered it helpful to report. Furthermore, this patient group was only followed up to two 
years, and there has been some concern of late device failures, as seen in large-joint arthroplasty 
3, although this hasn’t been documented in ACDR studies to date 23. 
Conclusion 
This is the first publication of clinical and radiological results following ACDR using the 
NuNec™ disk replacement.  In this cohort, clinical outcomes have been comparable with other 
studies of ACDR and show a beneficial effect on quality of life, and whilst range of movement is 
decreased at the two-year follow-up and HO is common as with other disk replacements, re-
operation rate was favorable. Furthermore, we have demonstrated no significant difference in 
outcome for patients presenting with radiculopathy or myelopathy, suggesting that ACDR is 
appropriate for both. 
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